Glucagon-like peptide-1 receptor agonist ameliorates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity through enhancing mitophagy flux and reducing -synuclein and oxidative stress
C16-carnitine exhibits complex dual-regulatory characteristics
Mochizuki for their technical assistance
Bolt Pharmacy Choline, Inositol & Fatty Liver: Evidence, Dosage and Guidance (choline UL, TMAO association, NICE guidance)
Effects in PCOS GLP-1 RAs have been extensively studied in women with PCOS due to overlapping metabolic abnormalities
These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers